Federal contractor profile
CISBIO US, INC.
UEI D3QENK4DJ9M4CAGE 574M2
Overview
- Legal name
- CISBIO US, INC.
- Latest award activity
- Aug 26, 2025
Read company summary
CISBIO US, INC. is associated with UEI D3QENK4DJ9M4 and CAGE 574M2 in public federal records. AcornBids currently links 1 prime award totaling $0 in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as In-Vitro Diagnostic Substance Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities.
At a glance
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 17, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- CISBIO US, INC.
- UEI
- D3QENK4DJ9M4
- CAGE
- 574M2
- Registration status
- SAM registration status unavailable
Research brief
Source facts
- Loaded prime-award records link 1 awards and $0 in reported obligations to this legal entity. Source
- Recorded awards include In-Vitro Diagnostic Substance Manufacturing (NAICS 325413); this classification is not proof of every company capability. Source
- An example award describes: ASSAY FOR THE DETECTION OF LYSOBISPHOSPHATIDIC ACID (LBPA) Source
Federal award analysis
Net transaction obligations by federal fiscal period.
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Histories follow awards currently assigned to this recipient and may include transactions under an earlier recipient. Coverage: 1 of 1 selected awards. Select a period to explore its awards.
Funding change
Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Percentage is unavailable when the prior period has no positive reported obligations.
| Measure | Reported value |
|---|---|
| Current period | Oct 1, 2025 – Sep 30, 2026 |
| Current obligations | Not reported |
| Prior period | Oct 1, 2024 – Sep 30, 2025 |
| Prior obligations | $-16.8K |
| Change | Not reported |
| Growth | Not comparable |
Where the work is performed
State tile map; darker tiles have larger absolute net obligations. Outlined tiles indicate net deobligations. Unshaded tiles have no reported transactions in this selection. Other locations appear in the table.
Agencies
| Category | Period obligations | Awards |
|---|---|---|
| Department of Health and Human Services | $-16.8K | 1 |
Offices
| Category | Period obligations | Awards |
|---|---|---|
| NATIONAL INSTITUTES OF HEALTH NIDA | $-16.8K | 1 |
Naics
| Category | Period obligations | Awards |
|---|---|---|
| 325413 — In-Vitro Diagnostic Substance Manufacturing | $-16.8K | 1 |
Psc
| Category | Period obligations | Awards |
|---|---|---|
| B504 — Chemical/Biological Studies and Analysis | $-16.8K | 1 |
Vehicles
| Category | Period obligations | Awards |
|---|---|---|
| Unclassified | $-16.8K | 1 |
States
| Category | Period obligations | Awards |
|---|---|---|
| MA | $-16.8K | 1 |
Set Asides
| Category | Period obligations | Awards |
|---|---|---|
| NO SET ASIDE USED. | $-16.8K | 1 |
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75N95020P00701ASSAY FOR THE DETECTION OF LYSOBISPHOSPHATIDIC ACID (LBPA) | Department of Health and Human Services | $0 | Sep 22, 2020 | Nov 21, 2020 |
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Not available |
| Source loaded | Aug 15, 2026 |
| Initial registration | Not available |
| Entity start | Not available |
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Reported subsidiary tree
Ownership follows reported parent UEIs.
- REVVITY INCUEI XURJMC9NS4L3
- CALIPER LIFE SCIENCES, INC.UEI S6MKCCSXLQ67
- CISBIO US, INC.UEI D3QENK4DJ9M4
- EUROIMMUN US INCORPORATEDUEI TLRGC9WLG3U7
- EXCELITAS TECHNOLOGIES CORP.UEI WMPWNLQJLJ71
- HORIZON DISCOVERY BIOSCIENCES LIMITEDUEI VTAJYAZW8MN1
- NEXCELOM BIOSCIENCE LLCUEI ZZ22CHAA5732
- QUEST DIAGNOSTICS TB LLCUEI T2KVXCKG7LA9
- REVVITY HEALTH SCIENCES, INC.UEI G2TETZJTELL4
- REVVITY OMICS INCUEI LDJULX8K6M85
- REVVITY SIGNALS SOFTWARE, INC.UEI YJRFVQ6WNJV7
Corporate family
Reported ownership links. Award and funding explorers can include this family.
| Legal entity | Reported parent UEI | Source loaded |
|---|---|---|
| REVVITY INC | XURJMC9NS4L3 | Sep 26, 2026 |
| CALIPER LIFE SCIENCES, INC. | XURJMC9NS4L3 | Sep 19, 2026 |
| CISBIO US, INC. | XURJMC9NS4L3 | Aug 15, 2026 |
| EUROIMMUN US INCORPORATED | XURJMC9NS4L3 | Oct 17, 2026 |
| EXCELITAS TECHNOLOGIES CORP. | XURJMC9NS4L3 | Sep 26, 2026 |
| HORIZON DISCOVERY BIOSCIENCES LIMITED | XURJMC9NS4L3 | Sep 26, 2026 |
| NEXCELOM BIOSCIENCE LLC | XURJMC9NS4L3 | Sep 26, 2026 |
| QUEST DIAGNOSTICS TB LLC | XURJMC9NS4L3 | Sep 19, 2026 |
| REVVITY HEALTH SCIENCES, INC. | XURJMC9NS4L3 | Sep 26, 2026 |
| REVVITY OMICS INC | XURJMC9NS4L3 | Sep 26, 2026 |
| REVVITY SIGNALS SOFTWARE, INC. | XURJMC9NS4L3 | Sep 26, 2026 |
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit